| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.03 |